Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to...
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Limelight Networks’ $300 Million Acquisition of Yahoo’s Edgecast
Goodwin Procter advised Limelight Networks on the deal. Paul, Weiss, Rifkind, Wharton & Garrison represented Edgecast, Inc. and funds managed by affiliates of Apollo in the...
JMI Equity’s $85 Million Investment in ServiceTrade
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $85 million growth investment in ServiceTrade. With the additional capital, ServiceTrade will increase the pace...
Sinch AB’s $1.9 Billion Acquisition of Pathwire
Goodwin Procter advised Pathwire on the deal, while K&L Gates and Gernandt & Danielsson advised Sinch AB. Pathwire, along with its private equity owner Thoma Bravo...
EQRx’s Merger with CM Life Sciences III
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
Symphony’s Acquisition of Cloud9 Technologies
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
ElevateBio’s $525 Million Series C Financing
Goodwin Procter LLP advised ElevateBio on the deal. ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, announced it...